Reihaneh Safavi‐Sohi

Author

Harvard University ORCID

Also Known As

Reihaneh Safavi-Sohi, Reihaneh Safavi-sohi, Reihaneh Safavisohi, Reihaneh Safavi‐Sohi

Publications

581

Citations

H-Index

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital Shahid Beheshti University Stanford University Sapienza University of Rome

About

Reihaneh Safavi‐Sohi is an author at Harvard University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	283
2	Natural Sciences	3	3	51
3	Engineering	2	2	214
4	Biochemistry	2	2	37
5	Biomedical Engineering	1	1	105

Reihaneh Safavi‐Sohi

Publications

433

Citations

H-Index

Page 1

	Year	Citations
Disease-specific protein corona sensor arrays may have disease detection capacity Giulio Caracciolo, Reihaneh Safavi‐Sohi, Reza Malekzadeh, Nanoscale Horizons Disease Detection CapacityProteomic TechnologyEngineeringMedicineProteomics	2019	109
Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors Reihaneh Safavi‐Sohi, Shokoofeh Maghari, Mohammad Raoufi, ACS Applied Materials & Interfaces NanoparticlesEngineeringBiomedical EngineeringActive TargetingTargeted Nps	2016	105
Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface Vahid Serpooshan, Sara Sheibani, Pooja Pushparaj, ACS Nano	2018	102
Identification of the Proteins Determining the Blood Circulation Time of Nanoparticles Cintia Marques, Mohammad Javad Hajipour, Célia Marets, ACS Nano	2023	48
4D-LQTA-QSAR and docking study on potent gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling Jahan B. Ghasemi, Reihaneh Safavi‐Sohi, Euzébio Guimarães Barbosa Molecular Diversity Molecular DockingMedicinal ChemistryDrug TargetBiochemistryMedicine	2011	25
The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine Elisabetta Vulpis, Francesca Giulimondi, Luca Digiacomo, Molecular Pharmaceutics NanotherapeuticsImmunologyWhole BloodImmunotherapyCovid-19	2021	18
Quasi 4D-QSAR and 3D-QSAR study of the pan class I phosphoinositide-3-kinase (PI3K) inhibitors Reihaneh Safavi‐Sohi, Jahan B. Ghasemi Medicinal Chemistry Research Molecular DockingMedicinal ChemistryMedicineNatural Sciences3D-qsar Study	2012	14
<scp>4‐Methyl</scp> morpholinium bis‐(thio)barbiturates: Synthesis, structure, anticancer evaluation, and <scp>CoMFA</scp> study Nader Noroozi Pesyan, Hamid Rashidnejad, Mohammad Ali Esmaeili, Journal of the Chinese Chemical Society Molecular PharmacologyMedicinal ChemistryNatural Product SynthesisPharmaceutical ScienceBiochemistry	2020	12

Page 1